Alzheimer’s disease, cerebral amyloid angiopathy, amyloid related imaging abnormalities (ARIA), anti amyloid antibodies, biomarkers, CAA-related inflammation (CAA-ri), cerebrospinal fluid, disease modifying therapy clinical trials, vascular risk factors for AD and inflammatory-CAA, WMH and MHs